ANKRD66

gene
On this page

Summary

ANKRD66 (ankyrin repeat domain 66, HGNC:44669) is a protein-coding gene on chromosome 6p12.3, encoding Ankyrin repeat domain-containing protein 66 (B4E2M5).

At a glance

  • Clinical variants (ClinVar): 52 total
  • MANE Select transcript: NM_001162435

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:44669
Approved symbolANKRD66
Nameankyrin repeat domain 66
Location6p12.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000230062
Ensembl biotypeprotein_coding
Entrez100287718

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000445060, ENST00000565422, ENST00000958136, ENST00000958137

RefSeq mRNA: 1 — MANE Select: NM_001162435 NM_001162435

CCDS: CCDS59024

Canonical transcript exons

ENST00000565422 — 5 exons

ExonStartEnd
ENSE000022281244675193746752111
ENSE000023148744675372246753950
ENSE000025812814674693346746990
ENSE000025870474675872346759506
ENSE000035653054674989646749979

Expression profiles

Bgee: expression breadth broad, 37 present calls, max score 91.93.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2293 / max 78.7724, expressed in 53 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
681420.189648
681430.027110
2040160.01265

Top tissues by expression

119 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130291.93gold quality
olfactory segment of nasal mucosaUBERON:000538689.59gold quality
fallopian tubeUBERON:000388974.52gold quality
right lungUBERON:000216764.90gold quality
endometriumUBERON:000129560.55gold quality
left uterine tubeUBERON:000130352.21gold quality
lungUBERON:000204850.73gold quality
prefrontal cortexUBERON:000045148.12gold quality
caudate nucleusUBERON:000187347.44gold quality
hypothalamusUBERON:000189844.54gold quality
upper lobe of left lungUBERON:000895244.19gold quality
Ammon’s hornUBERON:000195444.00gold quality
corpus callosumUBERON:000233643.46gold quality
temporal lobeUBERON:000187143.42gold quality
amygdalaUBERON:000187643.27gold quality
colonic epitheliumUBERON:000039741.37gold quality
hindlimb stylopod muscleUBERON:000425241.05gold quality
anterior cingulate cortexUBERON:000983541.03gold quality
bone marrow cellCL:000209240.77gold quality
frontal cortexUBERON:000187040.17gold quality
endocervixUBERON:000045840.15gold quality
cerebral cortexUBERON:000095638.88gold quality
nucleus accumbensUBERON:000188238.22gold quality
superior frontal gyrusUBERON:000266137.68silver quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
brainUBERON:000095536.27gold quality
bone marrowUBERON:000237135.22gold quality
monocyteCL:000057635.19gold quality
apex of heartUBERON:000209834.96gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes7.91

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

21 targeting ANKRD66, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-570-3P99.9672.414910
HSA-MIR-493-5P99.9672.472382
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-990299.8969.152250
HSA-MIR-312899.5067.851258
HSA-MIR-7109-5P99.1866.131057
HSA-MIR-328-5P99.0864.651000
HSA-MIR-6868-5P99.0665.691284
HSA-MIR-181A-2-3P98.9167.601168
HSA-MIR-6769B-5P98.7364.911092
HSA-MIR-6885-5P98.7164.33902
HSA-MIR-6769A-5P97.9964.16851
HSA-MIR-7113-5P97.8867.331735
HSA-MIR-4799-3P97.7865.97893
HSA-MIR-4720-5P97.4665.67893
HSA-MIR-5588-5P97.4665.70913
HSA-MIR-6856-3P96.4766.27781
HSA-MIR-118296.4164.89336
HSA-MIR-990096.0665.48557
HSA-MIR-1915-5P95.2565.78571

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioANKRD66ENSDARG00000090489
mus_musculusAnkrd66ENSMUSG00000096140
rattus_norvegicusAnkrd66ENSRNOG00000068669

Protein

Protein identifiers

Ankyrin repeat domain-containing protein 66B4E2M5 (reviewed: B4E2M5)

All UniProt accessions (2): B4E2M5, H3BTF0

UniProt curated annotations — full annotation on UniProt →

RefSeq proteins (1): NP_001155907* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002110Ankyrin_rptRepeat
IPR036770Ankyrin_rpt-contain_sfHomologous_superfamily
IPR050776Ank_Repeat/CDKN_InhibitorFamily

Pfam: PF12796

UniProt features (6 total): repeat 3, chain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-B4E2M5-F185.040.64

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 14 (showing top): chr6p12, FOSTER_TOLERANT_MACROPHAGE_DN, METTL14_TARGET_GENES, SRSF9_TARGET_GENES, MIR1915_5P, MIR1182, GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_CEREBRUM_ASTROCYTES, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS, NOTCH3_TARGET_GENES, TRAVAGLINI_LUNG_CILIATED_CELL, TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1

Protein interactions and networks

STRING

786 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ANKRD66ANKUB1A6NFN9545
ANKRD66HOATZQ6PI97540
ANKRD66LRRC71Q8N4P6490
ANKRD66FAM216BQ8N7L0469
ANKRD66MAP3K19Q56UN5446
ANKRD66TMEM273Q5T292423
ANKRD66WDR31Q8NA23418
ANKRD66DYNLT5Q8N7M0409
ANKRD66ODAPHQ17RF5398
ANKRD66CALHM2Q9HA72384
ANKRD66SERTAD4Q9NUC0375
ANKRD66TRAPPC8Q9Y2L5368
ANKRD66DAW1Q8N136365
ANKRD66TMC5Q6UXY8362
ANKRD66TMEM255AQ5JRV8361

IntAct

2 interactions, top by confidence:

ABTypeScore
ANKRD66psi-mi:“MI:0915”(physical association)0.370

ESM2 similar proteins: A6NK59, A7MB89, B4E2M5, P0C6P7, P0C927, Q08DV6, Q29RM5, Q3SX45, Q3SZE4, Q3UMR0, Q495B1, Q4V890, Q5R5S1, Q5REW9, Q5RFS1, Q5U2S6, Q5ZM55, Q6GPE5, Q7T3P8, Q810B6, Q8C0T1, Q8C6Y6, Q8CEF1, Q8CEL2, Q8HXA6, Q8K0L0, Q8N9B4, Q8VHS6, Q8WXH4, Q8WXK1, Q91ZT8, Q96DX5, Q96JP0, Q96NW4, Q96Q27, Q9BSK4, Q9CQ31, Q9GKW8, Q9H0C1, Q9P2R3

Diamond homologs: A0A084B9Z8, B4E2M5, P42773, Q03017, Q4FE45, Q4JHE0, Q502M6, Q60772, Q61982, Q6RI86, Q8BLA8, Q9R172, Q9UM47, A0A0R4IQZ2, A5WVX9, B3DN87, B8A4F0, C8VCL4, E1BLT8, E7F587, E7FH11, E9PTT0, E9QCD3, F1Q7H8, F1QAM1, F1QHM7, F1QX91, O60069, O74384, O80685, P14585, P42836, P59267, P59268, Q04629, Q0WQK2, Q10L01, Q21920, Q2T9W8, Q2TGI5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

52 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance48
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

417 predictions. Top by Δscore:

VariantEffectΔscore
6:46746986:AGACA:Adonor_gain1.0000
6:46746987:GACA:Gdonor_gain1.0000
6:46746987:GACAG:Gdonor_gain1.0000
6:46746989:CA:Cdonor_gain1.0000
6:46746991:G:GGdonor_gain1.0000
6:46749895:GGGCT:Gacceptor_gain1.0000
6:46749980:G:GGdonor_gain1.0000
6:46751932:CACA:Cacceptor_loss1.0000
6:46751934:CAGTT:Cacceptor_loss1.0000
6:46751935:A:AGacceptor_gain1.0000
6:46751935:A:Gacceptor_loss1.0000
6:46751935:AGTT:Aacceptor_gain1.0000
6:46751936:G:GCacceptor_gain1.0000
6:46751936:GT:Gacceptor_gain1.0000
6:46751936:GTT:Gacceptor_gain1.0000
6:46751936:GTTG:Gacceptor_gain1.0000
6:46751936:GTTGT:Gacceptor_gain1.0000
6:46752109:AAGG:Adonor_loss1.0000
6:46752112:GTGA:Gdonor_loss1.0000
6:46753709:T:TAacceptor_gain1.0000
6:46753951:G:GGdonor_gain1.0000
6:46746988:ACA:Adonor_gain0.9900
6:46746988:ACAGT:Adonor_loss0.9900
6:46746989:CAGT:Cdonor_loss0.9900
6:46746990:AGTA:Adonor_loss0.9900
6:46746991:GTA:Gdonor_loss0.9900
6:46749894:A:AGacceptor_gain0.9900
6:46749894:AG:Aacceptor_gain0.9900
6:46749895:G:GGacceptor_gain0.9900
6:46749895:GG:Gacceptor_gain0.9900

AlphaMissense

1650 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:46752082:G:CR100P0.991
6:46753811:G:CA140P0.989
6:46753908:C:AA172E0.985
6:46752099:G:CA106P0.984
6:46753805:T:CF138L0.984
6:46753807:T:AF138L0.984
6:46753807:T:GF138L0.984
6:46753790:T:AW133R0.983
6:46753790:T:CW133R0.983
6:46753809:C:AA139E0.983
6:46753907:G:CA172P0.983
6:46752102:G:CA107P0.981
6:46753812:C:AA140E0.980
6:46752088:C:GP102R0.979
6:46753877:G:CD162H0.979
6:46753896:C:AP168Q0.978
6:46753896:C:GP168R0.977
6:46752100:C:AA106D0.976
6:46751991:G:CA70P0.975
6:46752088:C:AP102Q0.975
6:46753792:G:CW133C0.975
6:46753792:G:TW133C0.975
6:46753879:C:AD162E0.975
6:46753879:C:GD162E0.975
6:46752096:T:AW105R0.974
6:46752096:T:CW105R0.974
6:46753779:C:TT129I0.973
6:46753800:C:AA136D0.972
6:46752103:C:AA107E0.971
6:46752063:G:CD94H0.970

dbSNP variants (sampled 300 via entrez): RS1000069057 (6:46759281 G>A), RS1000202916 (6:46746882 G>A,T), RS1000457613 (6:46754141 G>A), RS1001067536 (6:46748752 T>G), RS1001216448 (6:46751324 G>A), RS1001278496 (6:46751471 C>A,T), RS1001288036 (6:46746056 T>C), RS1001319820 (6:46745529 C>T), RS1001424845 (6:46746102 T>C,G), RS1001451783 (6:46759912 G>A), RS1001584183 (6:46751494 T>A,G), RS1001690987 (6:46757558 C>G,T), RS1001855212 (6:46756224 C>A,T), RS1002074491 (6:46756418 AG>A), RS1002405010 (6:46746920 G>A,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation2
Smokeincreases expression, increases abundance2
bisphenol Saffects cotreatment, increases methylation1
Fulvestrantaffects cotreatment, increases methylation1
Air Pollutantsincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.